David Allen
Concepts (474)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myostatin | 9 | 2011 | 24 | 2.100 |
Why?
| | Muscle, Skeletal | 35 | 2015 | 1794 | 1.860 |
Why?
| | Muscle Fibers, Skeletal | 16 | 2011 | 214 | 1.780 |
Why?
| | Myosin Heavy Chains | 18 | 2011 | 183 | 1.650 |
Why?
| | Antigens, Human Platelet | 7 | 2013 | 10 | 1.310 |
Why?
| | Isoantibodies | 6 | 2013 | 57 | 1.090 |
Why?
| | Food Deprivation | 4 | 2010 | 29 | 1.040 |
Why?
| | Muscular Atrophy | 5 | 2010 | 87 | 0.950 |
Why?
| | Gene Expression Regulation | 11 | 2010 | 2594 | 0.950 |
Why?
| | Physical Conditioning, Animal | 7 | 2020 | 242 | 0.860 |
Why?
| | Muscle Fibers, Fast-Twitch | 7 | 2010 | 18 | 0.850 |
Why?
| | Adaptation, Physiological | 10 | 2011 | 570 | 0.840 |
Why?
| | Promoter Regions, Genetic | 12 | 2010 | 1247 | 0.830 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2013 | 130 | 0.780 |
Why?
| | Hindlimb | 6 | 2011 | 132 | 0.650 |
Why?
| | Calcineurin | 5 | 2010 | 105 | 0.610 |
Why?
| | Integrin beta3 | 4 | 2013 | 14 | 0.550 |
Why?
| | Blood Platelets | 3 | 2011 | 380 | 0.520 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1468 | 0.520 |
Why?
| | Edetic Acid | 3 | 2013 | 46 | 0.490 |
Why?
| | Thrombocytopenia, Neonatal Alloimmune | 2 | 2013 | 2 | 0.480 |
Why?
| | Myoblasts | 3 | 2008 | 83 | 0.480 |
Why?
| | Hindlimb Suspension | 4 | 2010 | 11 | 0.470 |
Why?
| | Exercise | 4 | 2015 | 2192 | 0.440 |
Why?
| | Mice | 36 | 2011 | 18338 | 0.440 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 475 | 0.430 |
Why?
| | Space Flight | 4 | 2008 | 71 | 0.420 |
Why?
| | Elbow Joint | 2 | 2015 | 73 | 0.420 |
Why?
| | RNA, Messenger | 14 | 2010 | 2820 | 0.420 |
Why?
| | Muscle Development | 6 | 2010 | 113 | 0.410 |
Why?
| | Animals | 57 | 2020 | 38141 | 0.410 |
Why?
| | Integrin alpha2 | 1 | 2013 | 3 | 0.390 |
Why?
| | Weightlessness | 4 | 2008 | 40 | 0.390 |
Why?
| | Chelating Agents | 1 | 2013 | 72 | 0.380 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2011 | 25 | 0.360 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 17 | 0.350 |
Why?
| | Dexamethasone | 2 | 2010 | 366 | 0.340 |
Why?
| | Organ Size | 12 | 2010 | 461 | 0.340 |
Why?
| | Molecular Sequence Data | 10 | 2010 | 2910 | 0.330 |
Why?
| | CCAAT-Enhancer-Binding Protein-delta | 1 | 2010 | 6 | 0.330 |
Why?
| | Transcription Factors | 6 | 2020 | 1733 | 0.330 |
Why?
| | Tolloid-Like Metalloproteinases | 1 | 2010 | 1 | 0.330 |
Why?
| | Bone Morphogenetic Protein 1 | 1 | 2010 | 1 | 0.330 |
Why?
| | Smad Proteins | 2 | 2010 | 43 | 0.320 |
Why?
| | Elbow | 1 | 2011 | 56 | 0.320 |
Why?
| | Bariatric Surgery | 2 | 2026 | 245 | 0.320 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2010 | 93 | 0.310 |
Why?
| | Epitopes | 2 | 2011 | 480 | 0.300 |
Why?
| | Mice, Inbred C57BL | 12 | 2011 | 5989 | 0.290 |
Why?
| | Physical Exertion | 5 | 2015 | 205 | 0.290 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2008 | 93 | 0.280 |
Why?
| | Activin Receptors, Type II | 1 | 2008 | 12 | 0.270 |
Why?
| | DNA, Intergenic | 1 | 2008 | 29 | 0.270 |
Why?
| | Base Sequence | 7 | 2010 | 2180 | 0.270 |
Why?
| | Genes, MHC Class II | 1 | 2008 | 76 | 0.270 |
Why?
| | Motor Activity | 7 | 2005 | 723 | 0.270 |
Why?
| | CLOCK Proteins | 2 | 2020 | 9 | 0.270 |
Why?
| | Protein Isoforms | 7 | 2008 | 396 | 0.270 |
Why?
| | Adipose Tissue | 3 | 2011 | 644 | 0.260 |
Why?
| | Genotype | 4 | 2011 | 1853 | 0.250 |
Why?
| | MicroRNAs | 2 | 2010 | 689 | 0.250 |
Why?
| | Muscle Fibers, Slow-Twitch | 5 | 2010 | 24 | 0.250 |
Why?
| | Antibodies, Monoclonal | 4 | 2011 | 1511 | 0.240 |
Why?
| | Transfection | 7 | 2008 | 925 | 0.240 |
Why?
| | Obesity | 2 | 2011 | 3076 | 0.240 |
Why?
| | Drosophila Proteins | 3 | 2020 | 213 | 0.240 |
Why?
| | Cell Nucleus | 7 | 2001 | 593 | 0.240 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 839 | 0.230 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2007 | 153 | 0.230 |
Why?
| | Calcium Signaling | 2 | 2009 | 244 | 0.230 |
Why?
| | Interleukin-6 | 1 | 2009 | 772 | 0.220 |
Why?
| | Muscular Diseases | 2 | 2011 | 108 | 0.220 |
Why?
| | Forkhead Transcription Factors | 1 | 2006 | 207 | 0.220 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2004 | 5 | 0.220 |
Why?
| | Serum Response Factor | 1 | 2005 | 33 | 0.220 |
Why?
| | Circadian Rhythm | 3 | 2020 | 512 | 0.210 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2003 | 317 | 0.210 |
Why?
| | Platelet Transfusion | 2 | 2004 | 78 | 0.210 |
Why?
| | Growth Hormone | 4 | 1998 | 91 | 0.210 |
Why?
| | DNA-Binding Proteins | 4 | 2009 | 1487 | 0.210 |
Why?
| | Cells, Cultured | 8 | 2010 | 4127 | 0.200 |
Why?
| | Physical Endurance | 2 | 2002 | 276 | 0.200 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2011 | 2146 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2004 | 115 | 0.190 |
Why?
| | Cell Differentiation | 3 | 2010 | 2045 | 0.190 |
Why?
| | Growth Substances | 1 | 2002 | 138 | 0.190 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 975 | 0.190 |
Why?
| | Cell Line | 6 | 2010 | 2823 | 0.180 |
Why?
| | Mice, Transgenic | 6 | 2011 | 2189 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 95 | 0.180 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 165 | 0.180 |
Why?
| | Proteins | 1 | 2008 | 1020 | 0.170 |
Why?
| | Obesity, Morbid | 1 | 2026 | 288 | 0.170 |
Why?
| | Stress, Psychological | 1 | 2010 | 1153 | 0.170 |
Why?
| | Patient Compliance | 1 | 2026 | 587 | 0.170 |
Why?
| | Rats | 12 | 2011 | 5581 | 0.170 |
Why?
| | Male | 27 | 2026 | 72817 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2006 | 907 | 0.160 |
Why?
| | Nuclear Proteins | 3 | 2006 | 743 | 0.160 |
Why?
| | Heart | 4 | 2005 | 626 | 0.160 |
Why?
| | Circadian Clocks | 1 | 2020 | 59 | 0.160 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 57 | 0.150 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2020 | 48 | 0.150 |
Why?
| | Acclimatization | 1 | 2001 | 172 | 0.150 |
Why?
| | Binding Sites | 5 | 2007 | 1313 | 0.150 |
Why?
| | Corticosterone | 2 | 2010 | 242 | 0.150 |
Why?
| | Drosophila | 1 | 2020 | 167 | 0.150 |
Why?
| | Proteomics | 3 | 2020 | 1191 | 0.150 |
Why?
| | Fibronectins | 4 | 2002 | 132 | 0.140 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2009 | 325 | 0.140 |
Why?
| | Weight-Bearing | 3 | 2001 | 183 | 0.140 |
Why?
| | Mutation | 4 | 2011 | 4093 | 0.140 |
Why?
| | Pediatric Obesity | 1 | 2026 | 637 | 0.140 |
Why?
| | Muscle Proteins | 2 | 2010 | 242 | 0.140 |
Why?
| | Thrombocytopenia | 3 | 2004 | 203 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2582 | 0.130 |
Why?
| | Luciferases | 2 | 2008 | 152 | 0.120 |
Why?
| | Calcium | 1 | 2002 | 1190 | 0.120 |
Why?
| | Glucocorticoids | 2 | 2010 | 531 | 0.120 |
Why?
| | NFATC Transcription Factors | 2 | 2009 | 94 | 0.120 |
Why?
| | Protein Binding | 3 | 2020 | 2250 | 0.120 |
Why?
| | Female | 24 | 2026 | 78763 | 0.120 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 455 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 364 | 0.120 |
Why?
| | Humans | 34 | 2026 | 145491 | 0.110 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1995 | 11 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2010 | 3125 | 0.110 |
Why?
| | Prolactin | 1 | 1995 | 87 | 0.110 |
Why?
| | Microscopy, Confocal | 6 | 2001 | 318 | 0.110 |
Why?
| | Body Weight | 6 | 2003 | 970 | 0.110 |
Why?
| | Genetic Variation | 4 | 2007 | 988 | 0.110 |
Why?
| | Hypertrophy | 3 | 2001 | 128 | 0.100 |
Why?
| | Signal Transduction | 5 | 2009 | 5202 | 0.100 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 26 | 0.100 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 374 | 0.100 |
Why?
| | Immunoassay | 1 | 1994 | 108 | 0.100 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 2137 | 0.100 |
Why?
| | Species Specificity | 2 | 2020 | 573 | 0.100 |
Why?
| | Pituitary Neoplasms | 1 | 1995 | 190 | 0.100 |
Why?
| | Isometric Contraction | 2 | 2015 | 190 | 0.100 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 19 | 0.100 |
Why?
| | Infant, Newborn | 5 | 2013 | 6437 | 0.090 |
Why?
| | Aging | 2 | 2001 | 1940 | 0.090 |
Why?
| | Bacterial Proteins | 2 | 2011 | 991 | 0.090 |
Why?
| | Education | 1 | 2013 | 105 | 0.090 |
Why?
| | Range of Motion, Articular | 2 | 2015 | 428 | 0.090 |
Why?
| | Vancomycin Resistance | 2 | 2011 | 16 | 0.090 |
Why?
| | Apoptosis | 2 | 1999 | 2411 | 0.090 |
Why?
| | Blotting, Western | 3 | 2010 | 1162 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1585 | 0.090 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 2002 | 0.090 |
Why?
| | Gluconeogenesis | 2 | 2010 | 82 | 0.090 |
Why?
| | Antigen-Antibody Complex | 1 | 2011 | 70 | 0.090 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2008 | 156 | 0.090 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 81 | 0.080 |
Why?
| | Time Factors | 3 | 2010 | 7171 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 6 | 2003 | 2526 | 0.080 |
Why?
| | Protein Kinase C | 2 | 2002 | 250 | 0.080 |
Why?
| | Weight Loss | 2 | 2022 | 839 | 0.080 |
Why?
| | Genes, Bacterial | 2 | 2008 | 170 | 0.080 |
Why?
| | Muscle Fatigue | 2 | 2011 | 98 | 0.080 |
Why?
| | Running | 1 | 2013 | 230 | 0.080 |
Why?
| | Torque | 1 | 2011 | 82 | 0.080 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2010 | 15 | 0.080 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 29 | 0.080 |
Why?
| | Glucokinase | 1 | 2010 | 15 | 0.080 |
Why?
| | Tripartite Motif Proteins | 1 | 2010 | 39 | 0.080 |
Why?
| | 3T3 Cells | 3 | 2008 | 156 | 0.080 |
Why?
| | DNA | 4 | 2008 | 1451 | 0.080 |
Why?
| | Mice, Obese | 2 | 2008 | 67 | 0.080 |
Why?
| | Phosphatidylethanolamine Binding Protein | 1 | 2009 | 1 | 0.080 |
Why?
| | Quality of Life | 1 | 2022 | 3195 | 0.080 |
Why?
| | Oxazolidinones | 1 | 2009 | 17 | 0.080 |
Why?
| | Proteome | 2 | 2007 | 517 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1710 | 0.080 |
Why?
| | Adolescent | 6 | 2026 | 22485 | 0.070 |
Why?
| | Young Adult | 5 | 2026 | 14192 | 0.070 |
Why?
| | Thymus Gland | 1 | 2010 | 311 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2008 | 436 | 0.070 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 191 | 0.070 |
Why?
| | Skeletal Muscle Myosins | 1 | 2008 | 2 | 0.070 |
Why?
| | Body Temperature Regulation | 2 | 2007 | 107 | 0.070 |
Why?
| | RNA, Antisense | 1 | 2008 | 18 | 0.070 |
Why?
| | Follistatin-Related Proteins | 1 | 2008 | 2 | 0.070 |
Why?
| | Myogenic Regulatory Factors | 2 | 2005 | 45 | 0.070 |
Why?
| | MEF2 Transcription Factors | 2 | 2005 | 51 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 222 | 0.070 |
Why?
| | Spleen | 1 | 2010 | 511 | 0.070 |
Why?
| | Muscle Contraction | 1 | 2011 | 430 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 395 | 0.070 |
Why?
| | ADP Ribose Transferases | 1 | 2007 | 9 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2010 | 1304 | 0.070 |
Why?
| | Eating | 1 | 2010 | 388 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2015 | 72 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 210 | 0.070 |
Why?
| | Point Mutation | 1 | 2008 | 242 | 0.060 |
Why?
| | Up-Regulation | 1 | 2010 | 848 | 0.060 |
Why?
| | Cluster Analysis | 1 | 2008 | 517 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2008 | 535 | 0.060 |
Why?
| | Adult | 8 | 2022 | 40707 | 0.060 |
Why?
| | Cattle | 2 | 2008 | 977 | 0.060 |
Why?
| | Protein Kinases | 1 | 2008 | 314 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 751 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 456 | 0.060 |
Why?
| | NF-kappa B | 1 | 2010 | 660 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 380 | 0.060 |
Why?
| | Cerebrospinal Fluid | 1 | 2007 | 88 | 0.060 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2006 | 6 | 0.060 |
Why?
| | Leptin | 1 | 2008 | 248 | 0.060 |
Why?
| | Forkhead Box Protein O1 | 1 | 2006 | 35 | 0.060 |
Why?
| | MyoD Protein | 1 | 2006 | 31 | 0.060 |
Why?
| | Animals, Newborn | 4 | 2001 | 890 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 478 | 0.060 |
Why?
| | Dietary Fats | 1 | 2008 | 308 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2007 | 284 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2006 | 276 | 0.060 |
Why?
| | Feeding Behavior | 2 | 2022 | 694 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1049 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2007 | 218 | 0.060 |
Why?
| | Octamer Transcription Factor-1 | 1 | 2005 | 5 | 0.060 |
Why?
| | Phenotype | 6 | 2007 | 3157 | 0.060 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 452 | 0.060 |
Why?
| | Mice, Inbred Strains | 2 | 2002 | 396 | 0.060 |
Why?
| | Microspheres | 1 | 2005 | 142 | 0.060 |
Why?
| | Myocardium | 3 | 2005 | 932 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2008 | 3424 | 0.050 |
Why?
| | Biomarkers | 3 | 2013 | 4283 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 348 | 0.050 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 328 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2005 | 162 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2005 | 335 | 0.050 |
Why?
| | Life Style | 1 | 2007 | 483 | 0.050 |
Why?
| | Oligonucleotides | 1 | 2005 | 153 | 0.050 |
Why?
| | Affect | 1 | 2007 | 322 | 0.050 |
Why?
| | Plasmids | 1 | 2005 | 375 | 0.050 |
Why?
| | Cell Count | 3 | 2002 | 320 | 0.050 |
Why?
| | Drosophila melanogaster | 2 | 2014 | 237 | 0.050 |
Why?
| | Desmin | 1 | 2003 | 24 | 0.050 |
Why?
| | Blood Proteins | 1 | 2005 | 230 | 0.050 |
Why?
| | Gene Deletion | 1 | 2005 | 392 | 0.050 |
Why?
| | Peptide Fragments | 2 | 2000 | 693 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 407 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2002 | 22 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 372 | 0.050 |
Why?
| | Gene Expression | 4 | 2020 | 1478 | 0.050 |
Why?
| | Ionophores | 1 | 2002 | 21 | 0.050 |
Why?
| | Calcimycin | 1 | 2002 | 36 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2002 | 55 | 0.050 |
Why?
| | Liver | 1 | 2011 | 1895 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1212 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 859 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 850 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 2 | 2001 | 192 | 0.050 |
Why?
| | Gene Transfer Techniques | 2 | 2003 | 186 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2002 | 69 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 93 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 31 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2009 | 141 | 0.040 |
Why?
| | Motivation | 1 | 2007 | 602 | 0.040 |
Why?
| | Molecular Biology | 1 | 2002 | 57 | 0.040 |
Why?
| | Mice, SCID | 1 | 2002 | 369 | 0.040 |
Why?
| | Selection, Genetic | 1 | 1984 | 258 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 2054 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1769 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2004 | 645 | 0.040 |
Why?
| | Antibodies | 1 | 2004 | 398 | 0.040 |
Why?
| | NADH Tetrazolium Reductase | 1 | 2001 | 2 | 0.040 |
Why?
| | Phosphorylation | 3 | 2014 | 1707 | 0.040 |
Why?
| | Brain Injuries | 1 | 2007 | 507 | 0.040 |
Why?
| | Isoenzymes | 1 | 2002 | 297 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1996 | 0.040 |
Why?
| | Gravitation | 1 | 2001 | 22 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 287 | 0.040 |
Why?
| | Cell Movement | 2 | 2002 | 961 | 0.040 |
Why?
| | Child Abuse | 1 | 2007 | 552 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2007 | 110 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1953 | 0.040 |
Why?
| | Sarcomeres | 1 | 2001 | 98 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 306 | 0.040 |
Why?
| | Chemotactic Factors | 1 | 2000 | 43 | 0.040 |
Why?
| | Homozygote | 1 | 2001 | 200 | 0.040 |
Why?
| | Animal Care Committees | 1 | 2020 | 5 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2002 | 581 | 0.040 |
Why?
| | Factor IX | 1 | 2000 | 49 | 0.040 |
Why?
| | Diet | 1 | 2008 | 1280 | 0.040 |
Why?
| | Blood Glucose | 1 | 2010 | 2330 | 0.040 |
Why?
| | Heterozygote | 1 | 2001 | 313 | 0.040 |
Why?
| | Antigen-Antibody Reactions | 2 | 2002 | 50 | 0.040 |
Why?
| | Dependovirus | 1 | 2000 | 78 | 0.040 |
Why?
| | Reference Values | 1 | 2001 | 797 | 0.040 |
Why?
| | Transgenes | 1 | 2000 | 191 | 0.040 |
Why?
| | Propionates | 1 | 1999 | 38 | 0.040 |
Why?
| | Myosins | 2 | 2000 | 133 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 821 | 0.040 |
Why?
| | RNA Interference | 1 | 2020 | 473 | 0.040 |
Why?
| | Antigens, CD | 1 | 2002 | 557 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 335 | 0.030 |
Why?
| | Chromatography, Gel | 2 | 1995 | 128 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2009 | 1156 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2026 | 2950 | 0.030 |
Why?
| | Period Circadian Proteins | 2 | 2014 | 33 | 0.030 |
Why?
| | Oligopeptides | 1 | 2000 | 266 | 0.030 |
Why?
| | Cats | 2 | 1995 | 228 | 0.030 |
Why?
| | Genes, Insect | 1 | 1997 | 22 | 0.030 |
Why?
| | Wound Healing | 1 | 2000 | 355 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2008 | 393 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 257 | 0.030 |
Why?
| | Alcoholism | 1 | 1984 | 821 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1367 | 0.030 |
Why?
| | Cell Wall | 2 | 2011 | 59 | 0.030 |
Why?
| | DNA, Bacterial | 2 | 2008 | 347 | 0.030 |
Why?
| | Myalgia | 1 | 2015 | 13 | 0.030 |
Why?
| | Visual Analog Scale | 1 | 2015 | 34 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2000 | 562 | 0.030 |
Why?
| | Chromatography, Liquid | 2 | 2009 | 445 | 0.030 |
Why?
| | Mass Spectrometry | 3 | 2007 | 744 | 0.030 |
Why?
| | Hyperprolactinemia | 1 | 1995 | 6 | 0.030 |
Why?
| | Staphylococcal Infections | 2 | 2011 | 391 | 0.030 |
Why?
| | Chemical Fractionation | 1 | 1995 | 29 | 0.030 |
Why?
| | Decerebrate State | 1 | 1995 | 3 | 0.030 |
Why?
| | Myosin Subfragments | 1 | 1995 | 24 | 0.030 |
Why?
| | Pituitary Gland, Posterior | 1 | 1994 | 3 | 0.030 |
Why?
| | Molecular Weight | 1 | 1995 | 312 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 1995 | 246 | 0.030 |
Why?
| | Biological Assay | 1 | 1995 | 129 | 0.030 |
Why?
| | Atrophy | 1 | 1995 | 199 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 857 | 0.030 |
Why?
| | Isoantigens | 1 | 1994 | 17 | 0.030 |
Why?
| | Neuropeptides | 1 | 1994 | 75 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2014 | 17 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1994 | 178 | 0.030 |
Why?
| | Receptors, Somatotropin | 1 | 1993 | 10 | 0.030 |
Why?
| | Mice, Nude | 1 | 1995 | 678 | 0.020 |
Why?
| | United Kingdom | 1 | 1994 | 339 | 0.020 |
Why?
| | Coombs Test | 1 | 1992 | 5 | 0.020 |
Why?
| | Immunosorbent Techniques | 1 | 1992 | 18 | 0.020 |
Why?
| | Volition | 2 | 2003 | 34 | 0.020 |
Why?
| | Citrate (si)-Synthase | 2 | 2003 | 53 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 1992 | 123 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2000 | 978 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 1995 | 1261 | 0.020 |
Why?
| | Pregnancy | 3 | 1992 | 7197 | 0.020 |
Why?
| | Molecular Typing | 1 | 2011 | 21 | 0.020 |
Why?
| | Daptomycin | 1 | 2011 | 18 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2007 | 831 | 0.020 |
Why?
| | Leg | 1 | 2013 | 244 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2000 | 1076 | 0.020 |
Why?
| | HLA Antigens | 1 | 1992 | 238 | 0.020 |
Why?
| | Rh Isoimmunization | 1 | 1991 | 3 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 1992 | 197 | 0.020 |
Why?
| | Vancomycin | 1 | 2011 | 94 | 0.020 |
Why?
| | Rh-Hr Blood-Group System | 1 | 1991 | 15 | 0.020 |
Why?
| | Cell Cycle | 1 | 1993 | 595 | 0.020 |
Why?
| | Muscle Strength | 1 | 2013 | 332 | 0.020 |
Why?
| | Receptors, Fibronectin | 2 | 2000 | 6 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 378 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 177 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2009 | 54 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 6070 | 0.020 |
Why?
| | Rats, Wistar | 2 | 2001 | 449 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4559 | 0.020 |
Why?
| | Peptide Mapping | 2 | 2002 | 62 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 174 | 0.020 |
Why?
| | Biofilms | 1 | 2011 | 301 | 0.020 |
Why?
| | Oxidation-Reduction | 2 | 2003 | 1080 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 1994 | 2129 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2000 | 2207 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 553 | 0.020 |
Why?
| | Kinetics | 3 | 2000 | 1605 | 0.020 |
Why?
| | United States | 1 | 2026 | 16115 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 72 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2007 | 35 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 507 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 126 | 0.020 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 191 | 0.020 |
Why?
| | Lipocalins | 1 | 2007 | 35 | 0.020 |
Why?
| | Cystatin C | 1 | 2007 | 66 | 0.020 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2007 | 65 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 127 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 166 | 0.020 |
Why?
| | Haptoglobins | 1 | 2007 | 71 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 566 | 0.020 |
Why?
| | Immunoblotting | 1 | 2007 | 294 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2000 | 2664 | 0.010 |
Why?
| | Fibroblasts | 2 | 2003 | 1023 | 0.010 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 135 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1134 | 0.010 |
Why?
| | Cell Division | 2 | 2000 | 753 | 0.010 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 36 | 0.010 |
Why?
| | Albumins | 1 | 2005 | 119 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 73 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 82 | 0.010 |
Why?
| | Nicotine | 1 | 2007 | 334 | 0.010 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 1984 | 9 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1984 | 100 | 0.010 |
Why?
| | Purpura | 1 | 2004 | 18 | 0.010 |
Why?
| | Exploratory Behavior | 1 | 1984 | 85 | 0.010 |
Why?
| | Isomerism | 1 | 2003 | 57 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 437 | 0.010 |
Why?
| | Muscle Cells | 1 | 2003 | 41 | 0.010 |
Why?
| | Motor Skills | 1 | 1984 | 104 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 834 | 0.010 |
Why?
| | Protein Kinase C-epsilon | 1 | 2002 | 23 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2002 | 20 | 0.010 |
Why?
| | RNA Precursors | 1 | 2003 | 154 | 0.010 |
Why?
| | CHO Cells | 1 | 2002 | 166 | 0.010 |
Why?
| | Cricetinae | 1 | 2002 | 299 | 0.010 |
Why?
| | Coloring Agents | 1 | 2002 | 91 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 620 | 0.010 |
Why?
| | Electrophoresis | 1 | 2001 | 31 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 303 | 0.010 |
Why?
| | Animals, Suckling | 1 | 2000 | 5 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1047 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2000 | 84 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1468 | 0.010 |
Why?
| | Fatigue | 1 | 2002 | 364 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 31 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 93 | 0.010 |
Why?
| | Seizures | 1 | 1984 | 482 | 0.010 |
Why?
| | Putrescine | 1 | 1999 | 3 | 0.010 |
Why?
| | Oxaloacetic Acid | 1 | 1999 | 4 | 0.010 |
Why?
| | Autoimmune Diseases | 1 | 2004 | 469 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 1999 | 32 | 0.010 |
Why?
| | Formates | 1 | 1999 | 15 | 0.010 |
Why?
| | Virion | 1 | 2000 | 111 | 0.010 |
Why?
| | Citrates | 1 | 1999 | 40 | 0.010 |
Why?
| | Methylmalonic Acid | 1 | 1999 | 66 | 0.010 |
Why?
| | Citric Acid Cycle | 1 | 1999 | 59 | 0.010 |
Why?
| | Chemotaxis | 1 | 2000 | 123 | 0.010 |
Why?
| | Trehalose | 1 | 1999 | 35 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1999 | 318 | 0.010 |
Why?
| | Succinic Acid | 1 | 1999 | 46 | 0.010 |
Why?
| | Citric Acid | 1 | 1999 | 35 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 455 | 0.010 |
Why?
| | Pyruvic Acid | 1 | 1999 | 55 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 2000 | 119 | 0.010 |
Why?
| | Echocardiography | 1 | 2002 | 648 | 0.010 |
Why?
| | Keratinocytes | 1 | 2000 | 250 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 1999 | 144 | 0.010 |
Why?
| | Protons | 1 | 1999 | 97 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 567 | 0.010 |
Why?
| | Alanine | 1 | 1999 | 170 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2000 | 505 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2000 | 883 | 0.010 |
Why?
| | Glycine | 1 | 1999 | 186 | 0.010 |
Why?
| | DNA, Viral | 1 | 2000 | 357 | 0.010 |
Why?
| | Sex Factors | 1 | 1984 | 2110 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2000 | 691 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1999 | 256 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1116 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1094 | 0.010 |
Why?
| | Feedback | 1 | 1997 | 181 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1999 | 625 | 0.010 |
Why?
| | Exercise Test | 1 | 1999 | 628 | 0.010 |
Why?
| | Brain | 1 | 2007 | 2944 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1995 | 66 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 60 | 0.010 |
Why?
| | Age Factors | 1 | 2001 | 3340 | 0.010 |
Why?
| | Mass Screening | 1 | 2002 | 1358 | 0.010 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 1992 | 5 | 0.010 |
Why?
| | Infant | 1 | 2007 | 10064 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 11831 | 0.010 |
Why?
| | Adipocytes | 1 | 1993 | 223 | 0.010 |
Why?
| | Insulin | 2 | 1993 | 2506 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 11837 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 860 | 0.010 |
Why?
| | England | 1 | 1991 | 108 | 0.010 |
Why?
| | Collagen | 1 | 1992 | 453 | 0.000 |
Why?
| | Fetal Blood | 1 | 1991 | 325 | 0.000 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 497 | 0.000 |
Why?
| | Middle Aged | 1 | 2007 | 36176 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2915 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 17269 | 0.000 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|